SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor selloff is weighing on SOXL, with traders linking it to fears that the new congressional balance could bring tighter AI and data-center restrictions, alongside chip-sector weakness and concerns that the AI trade is unwinding. The community is split between expecting further losses and treating the decline as capitulation and a buying opportunity, while warning that SOXLs 3x leverage magnifies the swings.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Record quarterly results, expanding margins, and continued sales growth are driving discussion, though the stocks muted reaction frustrates bullish holders. Debate centers on whether improving commercial execution outweighs lingering concerns about lung-cancer data durability, the planned filing timeline, and managements communication.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms quarterly report and outlook are driving the selloff: traders are focused on sharply weaker handset sales and margin pressure from rising component costs, despite modestly beating estimates. Some see growth in automotive, data center and the SpaceX partnership as a longer-term offset, while others argue diversification has not yet replaced the smartphone business.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

A strong quarterly report, raised full-year revenue outlook, and managements view that Recorlev could reach blockbuster scale years earlier than expected are driving attention to XERS. Traders are celebrating the growth outlook and sharp rally, while takeover speculation is circulating but remains unconfirmed.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

A stronger-than-expected third-quarter report is driving attention, with traders welcoming portfolio growth led by Alani Nu and a positive initial share reaction. Debate centers on whether that growth can offset declining revenue in the core CELSIUS brand and compressed gross margins.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unitys quarterly results beat expectations, delivered its first GAAP profit since going public, and paired rapid Vector advertising growth with stronger guidance, driving a sharp post-earnings rally. Traders largely celebrated a potential turnaround and debated whether the move can hold, while some cautioned about resistance and speculated about short covering.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs strong quarterly results and upbeat outlook have been overshadowed by a sharp selloff alongside chip and AI stocks. Traders debate whether election-related fears about AI regulation and data-center expansion, stretched valuations, or broader sector pressure are driving the decline, while dip buyers argue the companys fundamentals remain intact.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm shares are under pressure after an earnings beat failed to reassure investors: weaker-than-hoped royalty growth and a largely in-line outlook raised doubts about how quickly AI and data-center demand will translate into recurring revenue. Traders also point to broader selling across semiconductor and AI stocks, while some view the pullback as a buying opportunity.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is caught in a memory-sector selloff as election results fuel fears that tighter AI and data-center rules could slow infrastructure growth and chip demand. Traders are split between calling the decline an overreaction given strong results and ongoing demand, and warning that weaker AI spending, memory-price cyclicality, and competition could pressure future earnings.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is under pressure as traders worry that calls for tighter AI regulation and potential data-center permitting delays could slow infrastructure spending, alongside concerns about circular financing and the sustainability of AI demand. The community is split between viewing these risks as signs of an AI-trade unwind and treating the selloff as an overreaction, with some buying the dip ahead of earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL Data

NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL Data NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL DataPR NewswireCAMBRIDGE, Mass., Nov. 2, 2026 Expanded package to include new neurofilament light chain (NfL) analysis; Health Canada confirms March 2027...

NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026

NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026 NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026PR NewswireCAMBRIDGE, Mass., Oct. 29, 2026 Presentation will...

NeuroSense Files U.S. Patent Application for Traumatic Brain Injury

NeuroSense Files U.S. Patent Application for Traumatic Brain Injury NeuroSense Files U.S. Patent Application for Traumatic Brain InjuryPR NewswireCAMBRIDGE, Mass., Oct. 19, 2026 Patent application seeks protection for PrimeC use in concussion, blast-related brain injury and chronic traumatic...

NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones

NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding MilestonesPR NewswireCAMBRIDGE, Mass., Oct. 13, 2026Shares continue to trade on Nasdaq pending the Panel's...

NeuroSense Provides Update on Nasdaq Listing Compliance

NeuroSense Provides Update on Nasdaq Listing Compliance NeuroSense Provides Update on Nasdaq Listing CompliancePR NewswireCAMBRIDGE, Mass., Oct. 2, 2026Company regains compliance with Nasdaq's minimum bid price requirement and intends to request a Nasdaq Hearings Panel hearing to seek additional...

NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference

NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities ConferencePR NewswireCAMBRIDGE, Mass., Sept. 28, 2026 Management will participate in the 5th Annual ROTH Healthcare Opportunities Conference...

NeuroSense Provides Business Update and Progress for the First Half of 2026

NeuroSense Provides Business Update and Progress for the First Half of 2026 NeuroSense Provides Business Update and Progress for the First Half of 2026PR NewswireCAMBRIDGE, Mass., Sept. 25, 2026 CAMBRIDGE, Mass., Sept. 25, 2026 /PRNewswire/ --Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the...

NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference

NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference PR Newswire CAMBRIDGE, Mass., Sept. 10, 2026 Company presentation on Tuesday, September 15 at 4:30 p.m. ETManagement will be available...

NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS

NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS PR Newswire CAMBRIDGE, Mass., Aug. 31, 2026 Three-part program - AI-enabled...

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market session. The company's market cap stands at $256.8 million.
NeuroSense Therapeutics (NASDAQ:NRSN) shares increasedread more...

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.

Current Price	$1.47
Prev Close	$1.42
Open	$1.47
Dividend Yield	0.00%
50-Day Moving Average	$5.07
Beta	0.99
Avg. Volume	24,367.58
PE Ratio	-0.12

52-Week High	$25.40
52-Week Low	$1.10
Market Capitalization	$2.69M
EPS (Annual)	-$8.73
Price to Book	0.64
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

NRSN Fundamentals